Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Preclinical
Sponsor : Google Ventures
Deal Size : $135.0 million
Deal Type : Series B Financing
Details : The funding will be used to progress chroma’s single-dose epigenetic editing therapies and support expansion of novel genetic medicine platform designed to enable precise gene regulation while preserving genomic integrity.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 03, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Preclinical
Sponsor : Google Ventures
Deal Size : $135.0 million
Deal Type : Series B Financing